Table 4

Differences in poor adherence to asthma controller medications between measures of structural and functional support

Dose count of poor medication adherenceSelf-report of poor medication adherence
UnadjustedAdjustedUnadjustedAdjusted
OR (95% CI)OR (95% CI)OR (95% CI)OR (95% CI)
Structural social support
 Socially isolated1.51 (0.79 to 2.87)1.80 (0.81 to 3.99)1.48 (0.85 to 2.61)0.86 (0.42 to 1.77)
 Socially connected
Functional social support
 Pooled
 Infrequent support0.49 (0.29 to 0.82)**0.51 (0.26 to 0.98)*0.47 (0.30 to 0.75)**0.81 (0.44 to 1.48)
 Frequent support
 Stratified by health status
Poor health status
 Infrequent support0.37 (0.15 to 0.82)*0.32 (0.11 to 0.92)*0.67 (0.32 to 1.28)1.18 (0.45 to 3.10)
 Frequent support
Adequate health status
 Infrequent support0.59 (0.28 to 1.27)0.47 (0.17 to 1.29)0.47 (0.23 to 0.95)*0.70 (0.29 to 1.73)
 Frequent support
  • Adjusted analyses controlling for age, race/ethnicity, income, education, health literacy, number of years with asthma, limitations in ADL and number of chronic conditions, beliefs about asthma controller medications.

  • In order to further account for confounding by health status and subsequent need of functional support, we stratified by poor health status (diagnosed with five or more chronic conditions or reported one or more ADL impairment). Adjusted stratified analyses were adjusted for age, race/ethnicity, income, education, health literacy, number of years with asthma, beliefs about asthma controller medications.

  • *p<0.05; **p<0.01; ***p<0.001.

  • ADL, activities of daily living.